Dong Lü
Direktor/Vorstandsmitglied bei Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd.
Profil
Dong Lü is currently a Director at Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd.
He was formerly a Director at InventisBio, Co., Ltd.
Dr. Lü holds a doctorate degree from China Pharmaceutical University.
Aktive Positionen von Dong Lü
| Unternehmen | Position | Beginn |
|---|---|---|
Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd.
 Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd. Air Freight/CouriersTransportation Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. engages in the provision of biopharmaceutical cold chain services. It operates under the following segments: innovative drug research and development and life science cold chain services, cold chain logistics for commercial circulation of medicine and equipment, international pharmaceutical cold chain service, cell therapy cold chain service, and sales of new materials and cold chain equipment segment. The company was founded on August 7, 2017 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | 01.05.2022 |
Ehemalige bekannte Positionen von Dong Lü
| Unternehmen | Position | Ende |
|---|---|---|
| INVENTISBIO CO., LIMITED | Direktor/Vorstandsmitglied | - |
Ausbildung von Dong Lü
| China Pharmaceutical University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INVENTISBIO CO., LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd.
Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd. Air Freight/CouriersTransportation Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. engages in the provision of biopharmaceutical cold chain services. It operates under the following segments: innovative drug research and development and life science cold chain services, cold chain logistics for commercial circulation of medicine and equipment, international pharmaceutical cold chain service, cell therapy cold chain service, and sales of new materials and cold chain equipment segment. The company was founded on August 7, 2017 and is headquartered in Shanghai, China. | Transportation |
